Restricted accessResearch articleFirst published online 2020-12
Platelet-to-hemoglobin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: A retrospective cohort study
IijimaRNdrepepaGMehilliJ, et al.Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials. Thromb Haemost2007; 98: 852–857.
2.
IsikTKurtMTanbogaIH, et al.The impact of admission red cell distribution width on long-term cardiovascular events after primary percutaneous intervention: A four-year prospective study. Cardiol J2016; 23: 281–288.
3.
PoludasuSMarmurJDWeedonJ, et al.Effect of hemoglobin level on long-term all-cause mortality after percutaneous coronary intervention in African-Americans. Am J Cardiol2009; 103: 1078–1082.
4.
ZhengYYWuTTChenY, et al.Gamma-glutamyl transferase-to-platelet ratio as a novel predictor of long-term adverse outcomes in patients after undergoing percutaneous coronary intervention: A retrospective cohort study. Thromb Haemost2019; 119: 1021–1030.
5.
XieXMaYTYangYN, et al.Personalized antiplatelet therapy according to CYP2C19 genotype after percutaneous coronary intervention: A randomized control trial. Int J Cardiol2013; 168: 3736–3740.
6.
LettinoMLeonardiSDe MariaE, et al.Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease. Eur J Prev Cardiol2017; 24(3_Suppl.): 61–70.
7.
Tóth-ZsámbokiEHorváthZHajtmanL, et al.Cardiac rehabilitation programme as a non-pharmacological platelet inhibitory tool in acute coronary syndrome survivors. Eur J Prev Cardiol2017; 24: 1148–1156.
8.
TramarinRPistuddiVMarescaL, et al.Surgical and Clinical Outcome Research (SCORE) Group. Patterns and determinants of functional and absolute iron deficiency in patients undergoing cardiac rehabilitation following heart surgery. Eur J Prev Cardiol2017; 24: 799–807.
